InvestorsHub Logo

Number sleven

03/10/22 4:03 PM

#372717 RE: sts66 #372714

Sts,
https://www.pacermonitor.com/public/case/37326596/Amarin_Pharma,_Inc_et_al_v_Hikma_Pharmaceuticals_USA_Inc_et_al
Amarin requested that the court both sever and enter a final decision.(dismissal with prejudice) A dismissal without prejudice is not considered a final ruling. This type of dismissal allows Amarin to file an amended complaint or refile suit at a later time. The reason for the request, is stated within the request. A final ruling is necessary so they can appeal.
Sleven,

Number sleven

03/10/22 4:48 PM

#372723 RE: sts66 #372714

Sts,
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168016207
I had a discussion with both Marjac and North about this.
Sleven,

marjac

03/10/22 5:24 PM

#372725 RE: sts66 #372714

For the ruling to be "Final" for purposes of Amarin being able to appeal the dismissal of Hikma, the entire case against Health Net must conclude, whether through trial, settlement, or motion practice.

Once that part of the case is concluded, the dismissal of Hikma is deemed Final for purposes of appeal, as all issues will have been resolved against all parties. Right now, all issues have not been resolved against all parties, because the Health Net part of the case is still being litigated.

The parties attempted to make the Hikma ruling Final by filing jointly to sever Hikma from the case, but Judge Andrews exercised his discretion by rejecting the joint request.

I hope this clarifies any questions that anybody has regarding the current procedural posture of the Delaware infringement case.